1 recruiting, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow PD-1: new trials by email Literature Review of PD-1 trials Research Report on PD-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SCRT + Chemo Targeted Immuno-neoadjuvant Therapy for High-risk pMMR/MSS RC Short-Course Radiotherapy, PD-1 monoclonal antibody, mFOLFOX6 regimen - Rectal Adenocarcinoma, High-Risk Cancer | Phase 3 | Recruiting | Sixth Affiliated Hospital, Sun Yat-sen University | 204 | 2026-05-20 | 2026-07-01 |
| Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer PD-1, Sorafenib - Advanced Liver Cancer | Phase 3 | Unknown | Guangxi Medical University | 50 | 2019-12-01 | 2019-11-14 |
Rectal Neoplasms (1)
Guangxi Medical University (1) · Sixth Affiliated Hospital, Sun Yat-sen University (1)
China (2)
Jun Huang, PhD (1)